These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 21865355)

  • 21. Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy.
    Bogazzi F; Aghini-Lombardi F; Cosci C; Lupi I; Santini F; Tanda ML; Miccoli P; Basolo F; Pinchera A; Bartalena L; Braverman LE; Martino E
    J Endocrinol Invest; 2002 Feb; 25(2):176-80. PubMed ID: 11929091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
    Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
    J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis.
    Campi I; Perego GB; Ravogli A; Groppelli A; Parati G; Persani L; Fugazzola L
    Eur J Endocrinol; 2019 Nov; 181(5):519-524. PubMed ID: 31536966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.
    Bogazzi F; Martino E; Dell'Unto E; Brogioni S; Cosci C; Aghini-Lombardi F; Ceccarelli C; Pinchera A; Bartalena L; Braverman LE
    J Endocrinol Invest; 2003 Jul; 26(7):635-40. PubMed ID: 14594114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
    Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone and the thyroid.
    Jabrocka-Hybel A; Bednarczuk T; Bartalena L; Pach D; Ruchała M; Kamiński G; Kostecka-Matyja M; Hubalewska-Dydejczyk A
    Endokrynol Pol; 2015; 66(2):176-86. PubMed ID: 25931048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approach to the patient with amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A rare cause of thyreotoxicosis].
    Sauer-Schulz A; Müssig K; Kurth R; Fend F; Teichmann R; Schnauder G
    Dtsch Med Wochenschr; 2010 Sep; 135(37):1798. PubMed ID: 20824601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction.
    Maqdasy S; Batisse-Lignier M; Auclair C; Desbiez F; Citron B; Thieblot P; Roche B; Lusson JR; Tauveron I
    Am J Cardiol; 2016 Apr; 117(7):1112-6. PubMed ID: 26853955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amiodarone-induced thyrotoxicosis. A review.
    Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Type 2 amiodarone-induced thyrotoxicosis: efficacy of glucocorticoid therapy, a retrospective analysis].
    Ermolaeva AS; Fadeev VV
    Probl Endokrinol (Mosk); 2024 Jan; 69(6):17-27. PubMed ID: 38311991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of amiodarone on the thyroid.
    Martino E; Bartalena L; Bogazzi F; Braverman LE
    Endocr Rev; 2001 Apr; 22(2):240-54. PubMed ID: 11294826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiodarone and thyroid.
    Eskes SA; Wiersinga WM
    Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23(6):735-51. PubMed ID: 19942150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone-induced thyroid dysfunction.
    Danzi S; Klein I
    J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiodarone and the thyroid: a 2012 update.
    Bogazzi F; Tomisti L; Bartalena L; Aghini-Lombardi F; Martino E
    J Endocrinol Invest; 2012 Mar; 35(3):340-8. PubMed ID: 22433945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
    Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
    Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of amiodarone-induced thyrotoxicosis.
    Osman F; Franklyn JA; Sheppard MC; Gammage MD
    Circulation; 2002 Mar; 105(11):1275-7. PubMed ID: 11901034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amiodarone and thyroid dysfunction.
    Padmanabhan H
    South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of amiodarone-associated thyrotoxicosis.
    Franklyn JA; Gammage MD
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):662-6. PubMed ID: 17710087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.